Test Identifies Ovarian Cancer

Published Online: Friday, October 1, 2004

John Hopkins researchers have developed a test to detect ovarian cancer by identifying 3 proteins found in the blood of women with the disease, according to an article reported in Cancer Research (August 15, 2004). Earlier studies with the test suggested that there is a molecular signature exclusive to ovarian cancer, which can remain undetected and spread quickly.

"By identifying a select group of biomarkers specific to ovarian cancer, we not only know the proteins we are dealing with, but we can trace them back to alterations in the genetic code of ovarian cancer cells," said Daniel W. Chan, PhD, director of Biomarker Discovery Center at Johns Hopkins.

Additional studies are needed, however, before the test is commercially available for screening ovarian cancer. Chan pointed out that no blood test will be able to correctly diagnose 100% of cancerous tumors all the time.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues